Skip to Main Content

Author Details

J??ri Reimand
Ontario Institute for Cancer Research
2007
71
36
PMIDPaper TitleJournal TitlePublished Year
36627300Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2023
37670013Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.Nat Commun2023
37922356Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes.Sci Adv2023
37258521In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.Nat Commun2023
37223041Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing.Front Endocrinol (Lausanne)2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
34556523Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer.Mol Cancer Res2022
35579274Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants.Mol Syst Biol2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36473869Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2022
36481658Author Correction: Integrative pathway enrichment analysis of multivariate omics data.Nat Commun2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35947558Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.PLoS Comput Biol2022
33941236Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.Genome Biol2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33834021ActiveDriverDB: Interpreting Genetic Variation in Human and Cancer Genomes Using Post-translational Modification Sites and Signaling Networks (2021 Update).Front Cell Dev Biol2021
34686327Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.Cell Rep2021
34475389Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.Nat Commun2021
32071079Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.J Biol Chem2020
31954095Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.Mol Cell2020
30664679Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap.Nat Protoc2019
31846472A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival.PLoS Genet2019
31292163ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.Cancer Res2019
29126202ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.Nucleic Acids Res2018
30140170Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates.Proteome Sci2018
30297829Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.Nat Commun2018
30389946Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.Nat Commun2018
29496907Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, <i>S</i>rc-<i>r</i>elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal <i>M</i>yristoylation <i>S</i>ites (SRMS).Mol Cell Proteomics2018
29415082SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.PLoS One2018
29625052Pathogenic Germline Variants in 10,389 Adult Cancers.Cell2018
29258295Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.Nature2018
28609654Intertumoral Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2017
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
26919435New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Cell2016
27582050Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders.Genome Biol2016
27175787Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.Genome Med2016
27575621Impact of outdated gene annotations on pathway enrichment analysis.Nat Methods2016
27098042g:Profiler-a web server for functional interpretation of gene lists (2016 update).Nucleic Acids Res2016
26771497Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.Cell2016
26760213Divergent clonal selection dominates medulloblastoma at recurrence.Nature2016
25561528Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.Proc Natl Acad Sci U S A2015
26436532Systematic analysis of somatic mutations impacting gene expression in 12 tumour types.Nat Commun2015
26258683EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.Nat Neurosci2015
26125594Pathway and network analysis of cancer genomes.Nat Methods2015
25965575Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.Cancer Cell2015
25938373MIMP: predicting the impact of mutations on kinase-substrate phosphorylation.Nat Methods2015
25611800Evolutionary constraint and disease associations of post-translational modification sites in human genomes.PLoS Genet2015
24651015Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.Cancer Cell2014
24713437HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery.Bioinformatics2014
  • 1 - 50 of 71

Recommended Authors

Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 2017
Number of shared co-authors 0
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 57
University of Lausanne, Switzerland Swiss Cancer Center Leman
Career Start Year 2012
Number of shared co-authors 9
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 44
University of California
Career Start Year 2008
Number of shared co-authors 10
Center for Computational Biomedicine, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Broad Institute of Harvard and MIT
Career Start Year 2007
Number of shared co-authors 9
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 41
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 2006
Number of shared co-authors 7
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 11
Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 3
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 36
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 14
Pfizer Inc.
Career Start Year 2004
Number of shared co-authors 1
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 7
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 6
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 19
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 44
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 29
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 5
Institute of Statistical Science
Career Start Year 2001
Number of shared co-authors 3
Weill Institute for Cell and Molecular Biology, Cornell University
Career Start Year 2001
Number of shared co-authors 7
Lewis-Sigler Institute for Integrative Genomics, Princeton University
Career Start Year 2001
Number of shared co-authors 6
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 27
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 1998
Number of shared co-authors 9
University of California San Diego
Career Start Year 1996
Number of shared co-authors 14
Columbia University
Career Start Year 1993
Number of shared co-authors 31
University of California San Diego
Career Start Year 1992
Number of shared co-authors 41

Collaborators

University of Toronto
Co-authored papers 23
The Hospital for Sick Children
Co-authored papers 16
Institute of Computer Science, University of Tartu
Co-authored papers 14
Hospital for Sick Children
Co-authored papers 12
The Hospital for Sick Children, University of Toronto
Co-authored papers 11
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 10
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 9
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 9
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 9
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Institute of Computer Science, University of Tartu
Co-authored papers 8
The Hospital for Sick Children
Co-authored papers 8
Cumming School of Medicine, University of Calgary
Co-authored papers 8
University of Wollongong
Co-authored papers 8
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 7
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 7
Institut Curie, PSL Research University
Co-authored papers 7
University of California san francisco
Co-authored papers 7
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 7
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 6
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 6
The Hospital for Sick Children
Co-authored papers 6
University of British Columbia
Co-authored papers 6
Co-authored papers 6
Institute of Machines and Motor Vehicles, Poznan University of Technology
Co-authored papers 6
University of British Columbia
Co-authored papers 6
BioBox Analytics Inc.
Co-authored papers 6
Seoul National University Children's Hospital
Co-authored papers 6
Kitasato University School of Medicine
Co-authored papers 6
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 6